Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JS']JSMO, KSMO, MOS and SSO

被引：174

作者：

Chen, L-T ^{[1
,2
,3
]}

Martinelli, E. ^{[4
]}

Cheng, A-L ^{[5
,6
]}

Pentheroudakis, G. ^{[7
]}

Qin, S. ^{[8
]}

Bhattacharyya, G. S. ^{[9
]}

Ikeda, M. ^{[10
]}

Lim, H-Y ^{[11
]}

Ho, G. F. ^{[12
]}

Choo, S. P. ^{[13
,14
]}

Ren, Z. ^{[15
]}

Malhotra, H. ^{[16
]}

Ueno, M. ^{[17
]}

Ryoo, B-Y ^{[18
]}

Kiang, T. C. ^{[19
]}

Tai, D. ^{[20
]}

Vogel, A. ^{[21
]}

Cervantes, A. ^{[22
]}

Lu, S-N ^{[23
]}

Yen, C-J ^{[2
]}

Huang, Y-H ^{[24
,25
]}

Chen, S-C ^{[26
]}

Hsu, C. ^{[6
,27
]}

Shen, Y-C ^{[5
]}

Tabernero, J. ^{[28
,29
]}

Yen, Y. ^{[30
]}

Hsu, C-H ^{[5
,27
]}

Yoshino, T. ^{[10
]}

Douillard, J-Y ^{[31
]}

机构：

[1] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan

[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan

[3] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[4] Univ Campania L Vanvitelli, Dept Clin & Expt Med F Magrassi Med Oncol, Naples, Italy

[5] Natl Taiwan Univ, Canc Ctr, Dept Med Oncol, Taipei, Taiwan

[6] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan

[7] Univ Ioannina, Dept Med Oncol, Ioannina, Greece

[8] Jinling Hosp, Chinese PLA Canc Ctr, Nanjing, Peoples R China

[9] Salt Lake City Med Ctr, Kolkata, India

[10] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan

[11] Sungkyunkwan Univ, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea

[12] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia

[13] Curie Oncol, Singapore, Singapore

[14] Natl Canc Ctr Singapore, Singapore, Singapore

[15] Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China

[16] Mahatma Gandhi Med Coll Hosp, Sri Ram Canc Ctr, Dept Med Oncol, Jaipur, Rajasthan, India

[17] Kanagawa Canc Ctr, Hepatobiliary & Pancreat Med Oncol Div, Dept Gastroenterol, Yokohama, Kanagawa, Japan

[18] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea

[19] Hosp Umum Sarawak, Sarawak, Malaysia

[20] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore

[21] Med Sch Hannover, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany

[22] Univ Valencia, INCLIVIA, Inst Hlth Res, Dept Med Oncol,CIBERONC, Valencia, Spain

[23] Chiayi Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Chiayi, Taiwan

[24] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[25] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan

[26] Taipei Vet Gen Hosp, Dept Oncol, Div Med Oncol, Taipei, Taiwan

[27] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei, Taiwan

[28] Vall dHebron Univ Hosp, Med Oncol Dept, Barcelona, Spain

[29] UVic, IOB Quiron, Inst Oncol VHIO, Barcelona, Spain

[30] Taipei Med Univ, Taipei, Taiwan

[31] ESMO, Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2020年 / 31卷 / 03期

关键词：

consensus; ESMO guidelines; HCC; hepatocellular carcinoma; Pan-Asian; RANDOMIZED PHASE-III; ARTERIAL INFUSION CHEMOTHERAPY; PRIMARY LIVER-CANCER; HEPATITIS-B-VIRUS; INTERNAL RADIATION-THERAPY; TRANSARTERIAL CHEMOEMBOLIZATION; COST-EFFECTIVENESS; CONTROLLED-TRIAL; DOUBLE-BLIND; HEPATOBILIARY PHASE;

D O I：

10.1016/j.annonc.2019.12.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of hepatocellular carcinoma (HCC) was published in 2018, and covered the diagnosis, management, treatment and follow-up of early, intermediate and advanced disease. At the ESMO Asia Meeting in November 2018 it was decided by both the ESMO and the Taiwan Oncology Society (TOS) to convene a special guidelines meeting immediately after the Taiwan Joint Cancer Conference (TJCC) in May 2019 in Taipei. The aim was to adapt the ESMO 2018 guidelines to take into account both the ethnic and the geographic differences in practice associated with the treatment of HCC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with intermediate and advanced/relapsed HCC representing the oncology societies of Taiwan (TOS), China (CSCO), India (ISMPO) Japan (JSMO), Korea (KSMO), Malaysia (MOS) and Singapore (SSO). The voting was based on scientific evidence, and was independent of the current treatment practices, the drug availability and reimbursement situations in the individual participating Asian countries.

引用

页码：334 / 351

页数：18

共 122 条

[61] Transarterial chemoembolization can prolong survival for patients with metastatic hepatocellular carcinoma: a propensity score matching analysis [J].

Lee, I-Cheng ;

Huo, Teh-Ia ;

Huang, Yi-Hsiang ;

Chao, Yee ;

Li, Chung-Pin ;

Lee, Pui-Ching ;

Chiang, Jen-Huey ;

Su, Chien-Wei ;

Lan, Keng-Hsin ;

Yang, Chih-Ming ;

Wu, Jaw-Ching ;

Lin, Han-Chieh ;

Lee, Shou-Dong .

HEPATOLOGY INTERNATIONAL, 2012, 6 (04) :753-762

[62] Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging-A Systematic Review and Meta-Analysis [J].

Lee, Yoon Jin ;

Lee, Jeong Min ;

Lee, Ji Sung ;

Lee, Hwa Young ;

Park, Bo Hyun ;

Kim, Young Hoon ;

Han, Joon Koo ;

Choi, Byung Ihn .

RADIOLOGY, 2015, 275 (01) :97-109

[63] Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC [J].

Lencioni, Riccardo ;

Montal, Robert ;

Torre, Ferran ;

Park, Joong-Won ;

Decaens, Thomas ;

Raoul, Jean-Luc ;

Kudo, Masatoshi ;

Chang, Charissa ;

Rios, Jose ;

Boige, Valerie ;

Assenat, Eric ;

Kang, Yoon-Koo ;

Lim, Ho-Yeong ;

Walters, Ian ;

Llovet, Josep M. .

JOURNAL OF HEPATOLOGY, 2017, 66 (06) :1166-1172

[64] Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial [J].

Lencioni, Riccardo ;

Llovet, Josep M. ;

Han, Guohong ;

Tak, Won Young ;

Yang, Jiamei ;

Guglielmi, Alfredo ;

Paik, Seung Woon ;

Reig, Maria ;

Kim, Do Young ;

Chau, Gar-Yang ;

Luca, Angelo ;

Ruiz del Arbol, Luis ;

Leberre, Marie-Aude ;

Niu, Woody ;

Nicholson, Kate ;

Meinhardt, Gerold ;

Bruix, Jordi .

JOURNAL OF HEPATOLOGY, 2016, 64 (05) :1090-1098

[65] Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma [J].

Lencioni, Riccardo ;

Llovet, Josep M. .

SEMINARS IN LIVER DISEASE, 2010, 30 (01) :52-60

[66] A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization [J].

Lewandowski, R. J. ;

Kulik, L. M. ;

Riaz, A. ;

Senthilnathan, S. ;

Mulcahy, M. F. ;

Ryu, R. K. ;

Ibrahim, S. M. ;

Sato, K. T. ;

Baker, T. ;

Miller, F. H. ;

Omary, R. ;

Abecassis, M. ;

Salem, R. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (08) :1920-1928

[67] The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2 [J].

Lin, Chen-Chun ;

Cheng, Ya-Ting ;

Chen M, Wei-Ting ;

Lin, Shi-Ming .

LIVER CANCER, 2016, 5 (01) :8-20

[68] Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival [J].

Llovet, JM ;

Bruix, J .

HEPATOLOGY, 2003, 37 (02) :429-442

[69] Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial [J].

Llovet, JM ;

Real, MI ;

Montaña, X ;

Planas, R ;

Coll, S ;

Aponte, J ;

Ayuso, C ;

Sala, M ;

Muchart, J ;

Solà, R ;

Rodés, J ;

Bruix, J .

LANCET, 2002, 359 (9319) :1734-1739

[70] Sorafenib in advanced hepatocellular carcinoma [J].

Llovet, Josep M. ;

Ricci, Sergio ;

Mazzaferro, Vincenzo ;

Hilgard, Philip ;

Gane, Edward ;

Blanc, Jean-Frederic ;

Cosme de Oliveira, Andre ;

Santoro, Armando ;

Raoul, Jean-Luc ;

Forner, Alejandro ;

Schwartz, Myron ;

Porta, Camillo ;

Zeuzem, Stefan ;

Bolondi, Luigi ;

Greten, Tim F. ;

Galle, Peter R. ;

Seitz, Jean-Francois ;

Borbath, Ivan ;

Haussinger, Dieter ;

Giannaris, Tom ;

Shan, Minghua ;

Moscovici, Marius ;

Voliotis, Dimitris ;

Bruix, Jordi .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (04) :378-390

← 2 3 4 5 6 7 8 9 10 11 →